Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

BACKGROUND: Recent studies strongly suggest that due to the limitations and risks of biopsy, as well as the improvement of the diagnostic accuracy of biochemical markers, liver biopsy should no longer be considered mandatory in patients with chronic hepatitis C. In 2001, FibroTest ActiTest (FT-AT),...

Popoln opis

Bibliografske podrobnosti

izdano v:	Comp Hepatol
Principais autores:	Poynard, Thierry, Imbert-Bismut, Françoise, Munteanu, Mona, Messous, Djamila, Myers, Robert P, Thabut, Dominique, Ratziu, Vlad, Mercadier, Anne, Benhamou, Yves, Hainque, Bernard
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2004
Teme:	Research
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC522750/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15387887/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1476-5926-3-8
Oznake:	Označite Brez oznak, prvi označite!